Cizzle Biotechnology Holdings Plc (LON:CIZ)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1.550
+0.150 (10.71%)
At close: Mar 6, 2026
9,294%
Market Cap 6.14M
Revenue (ttm) n/a
Net Income (ttm) -1.12M
Shares Out 396.39M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,142,502
Average Volume 514,578
Open 1.400
Previous Close 1.400
Day's Range 1.420 - 1.700
52-Week Range 0.012 - 1.700
Beta 0.51
RSI 58.44
Earnings Date Apr 30, 2026

About LON:CIZ

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Employees 4
Stock Exchange London Stock Exchange
Ticker Symbol CIZ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.